Multivessel TALENT Trial – Supraflex Cruz vs Synergy DES in Triple Vessel Coronary Artery Disease

Devices

Supraflex Cruz*

Supraflex Cruz is a next-generation DES designed for excellent deliverability, and vessel conformability. Its open-cell design with Long Dual Z links improves flexibility, and facilitates navigation in complex anatomies. The broad size matrix, extensive overexpansion, large cell size, and side branch expansion capability make it suitable for bifurcation lesions. Supported by over 35,000 patients’ data, multiple randomized controlled trials, and a strong evidence in complex anatomies and high-risk cohorts, the Supraflex Cruz is one of the extensively studied coronary stents globally.

For more information, please visit

Synergy#

The Synergy stent is an everolimus-eluting drug-eluting stent with a bioabsorbable polymer coating. It is built on a platinum-chromium alloy platform with a laser-cut open-cell design.

For more information, please visit

Disclaimer: *Supraflex Cruz™ is a trademark of Sahajanand Medical Technologies Ltd. or its affiliates. #Synergy™ is a trademark of Boston Scientific Corporation or its affiliates. All trademarks are the property of their respective owners. This website provides general study information for research and educational purposes and is not a substitute for professional medical advice.

Scroll to Top